Pyrazole Derivatives
Patent Information
- Application Number
- JP2021545858
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2019-02-05
- Filing Date
- 2020-02-04
- Publication Date
- 2024-11-15
- Estimated Expiration
- 2040-02-04
Smart Images

Figure 0007584422000001 
Figure 0007584422000002 
Figure 0007584422000003
Abstract
Description
[Technical field]
[0001] The present invention relates to pyrazole derivatives of formula (X) as described herein which are important intermediates in the manufacture of agrochemicals and pharmaceuticals. The invention extends to the manufacture of such pyrazole derivatives and their subsequent use in the manufacture of agrochemicals and / or pharmaceuticals. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0002] In a first aspect, the present invention provides a compound of formula (X): [ka] (Wherein, ring A has one ring nitrogen atom bonded to R B2 and at least one ring carbon is R B3 and R is a di- or tri-substituted pyrazole substituted with B2 is C1-C3 alkyl or C1-C3 fluoroalkyl, n is an integer of 1 or 2, and each R B3 are independently halogen, C1-C3 fluoroalkyl, C1-C3 haloalkoxy, C1-C3 alkoxy, C1-C3 haloalkyl, C1-C3 fluoroalkyl, C1-C3 haloalkoxy, C1-C3 alkoxy, or C1-C3 alkyl; R Q1 and R Q4 are hydrogen, and R Q2 and R Q3 together with the carbon atoms to which they are attached form an optionally substituted 5-membered thiolactam ring, ring Q).
[0003] In a second embodiment, ring Q is R 1 There is provided a process for the preparation of a compound of formula (X) as defined above, which is substituted with (i) reacting a compound of formula (A) with ethyl acrylate under palladium catalysis to obtain a compound of formula (B): [ka] wherein ring A is a pyrazole ring substituted at a ring carbon with Hal, Hal being iodo, bromo, or chloro; R B2 is a substituent on the ring nitrogen, which is C1-C3 alkyl or C1-C3 fluoroalkyl, n is an integer of 1 or 2, R B3 are substituents on the ring carbons, and each R B3 are independently halogen, C1-C3 fluoroalkyl, C1-C3 haloalkoxy, C1-C3 alkoxy, C1-C3 haloalkyl, C1-C3 fluoroalkyl, C1-C3 haloalkoxy, C1-C3 alkoxy, or C1-C3 alkyl; (ii) reacting the compound of formula (B) from step (i) with a compound of formula (C) in a cycloaddition reaction to obtain a mixture of compounds of formula (D) and (E): [ka] (In the formula, R 1 is C1-C6 alkyl, C2-C6 alkenyl, C3-C6 cycloalkyl, C3-C6 cycloalkenyl, optionally substituted phenyl, optionally substituted C5-C6 heteroaryl, -CR 12 R 13 , -C(O)R 12 R 12 is hydrogen, OH, C1-C3 alkoxy, or C1-C4 alkyl; R 13 is -C(O)NH2); (iii) reacting a compound of formula (E) with a hydroxide base in a water / ether mixed solvent system to obtain a compound of formula (X): [ka] (In the formula, A, R B2 , R B3 , n, and R 1 is as defined in steps (i) and (ii) above); Includes.
[0004] Compounds of formulae (B), (D) and (E) are also novel and form further aspects of the invention.
[0005] The terms "halogen" or "halo", as used herein, unless otherwise specified, refer to fluorine (fluoro), chlorine (chloro), bromine (bromo), or iodine (iodo), preferably fluorine, chlorine, or bromine.
[0006] As used herein, cyano refers to the group -CN.
[0007] As used herein, hydroxy refers to the group --OH.
[0008] As used herein, nitro refers to the group --NO.sub.2.
[0009] Each alkyl moiety, alone or as part of a larger group (alkoxy, alkylthio, haloalkyl, haloalkoxy, etc.), may be linear or branched, and as used herein the term explicitly includes cyclopropyl. Typically, alkyl is, for example, methyl, ethyl, n-propyl, cyclopropyl, isopropyl, n-butyl, sec-butyl, isobutyl, tert-butyl, n-pentyl, neopentyl, or n-hexyl. Alkyl groups are generally C1-C6 alkyl groups (unless already defined more narrowly), but are preferably C1-C4 alkyl or C1-C3 alkyl groups, and more preferably C1 or C2 alkyl groups (i.e., methyl or ethyl).
[0010] As used herein, the term "C1-C3 alkoxy" refers to a group of the formula -OR a R in the formula a is a C1-C3 alkyl radical as generally defined above. Thus, examples of C1-C3 alkoxy include methoxy, ethoxy, propoxy, and iso-propoxy.
[0011] The term "C1-C3 haloalkyl" as used herein refers to a C1-C3 alkyl radical as generally defined above, substituted with one or more halogen atoms, which may be the same or different. Thus, examples of C1-C3 haloalkyl include fluoromethyl, difluoromethyl, trifluoromethyl, chloromethyl, dichloromethyl, trichloromethyl, 2,2,2-trifluoroethyl, 2-fluoroethyl, 2-chloroethyl, pentafluoroethyl, 1,1-difluoro-2,2,2-trichloroethyl, 2,2,3,3-tetrafluoroethyl, and 2,2,2-trichloroethyl.
[0012] The term "C1-C3 haloalkoxy" as used herein refers to a C1-C3 alkoxy group as defined above substituted with one or more halogen atoms, which may be the same or different. Thus, examples of C1-C3 haloalkoxy include fluoromethoxy, difluoromethoxy, trifluoromethoxy, 2,2,2-trifluoroethoxy, 1,1,2,2-tetrafluoroethoxy, 2-fluoroethoxy, 2-chloroethoxy, 2,2-difluoroethoxy, and 2,2,2-trichloroethoxy.
[0013] The term "C1-C6 alkylthio" refers to a C1-C6 alkyl-S- group, for example, methylthio, ethylthio, propylthio, isopropylthio, n-butylthio, isobutylthio, sec-butylthio, or tert-butylthio, preferably methylthio or ethylthio.
[0014] The term "C1-C6 alkylsulfinyl" refers to a C1-C6 alkyl-S(O)- group, for example, methylsulfinyl, ethylsulfinyl, propylsulfinyl, isopropylsulfinyl, n-butylsulfinyl, isobutylsulfinyl, sec-butylsulfinyl, or tert-butylsulfinyl, preferably methylsulfinyl or ethylsulfinyl.
[0015] The term "C1-C6 alkylsulfonyl" refers to a C1-C6 alkyl-S(O)2- group, such as methylsulfonyl, ethylsulfonyl, propylsulfonyl, isopropylsulfonyl, n-butylsulfonyl, isobutylsulfonyl, sec-butylsulfonyl, or tert-butylsulfonyl, preferably methylsulfonyl or ethylsulfonyl.
[0016] The compounds of formula (X) may exist as different geometric isomers or in different tautomeric forms. The present invention includes the use of all such isomers and tautomers, and mixtures thereof in all ratios, as well as isotopic forms such as deuterated compounds. They may contain one or more asymmetric centers, thus giving rise to optical isomers and diastereomers. Although formula (X) is shown without regard to stereochemistry, the present invention includes the use of all such optical isomers and diastereomers, as well as racemic and resolved enantiomerically pure R and S stereoisomers, and other mixtures of R and S stereoisomers, and pesticidally acceptable salts thereof. It is recognized that certain optical isomers or diastereomers may have preferred properties over others. Thus, when racemic mixtures are disclosed in disclosing and claiming the present invention, it is expressly intended to also disclose and claim both optical isomers, including diastereomers substantially free of the other.
[0017] Similarly, the presence of one or more potentially asymmetric carbon atoms in the compounds of formulae (D), (E), (H), and (I) means that these compounds can also occur in chiral isomeric forms, i.e., enantiomeric or diastereomeric forms. Atropisomers may also occur as a result of restricted rotation around a single bond. Formulae (D), (E), (H), and (I) are intended to include all their possible isomeric forms and mixtures thereof. The present invention includes the use of all their possible isomeric forms and mixtures thereof for the compounds of formulae (D), (E), (H), and (I). Similarly, formulae (D), (E), (H), and (I) are intended to include all possible tautomers, if present, including lactam-lactim tautomerism and keto-enol tautomerism. Thus, the present invention includes the use of all possible tautomeric forms for the compounds of formulae (D), (E), (H), and (I).
[0018] Suitable salts include those derived from alkali or alkaline earth metals, as well as those derived from ammonia and amines. Preferred cations include those of the formula N + (R 119 R 120 R 121 R 122 ) sodium, potassium, magnesium, and ammonium cations, 119 , R 120 , R 121 , and R 122 is independently selected from hydrogen, C1-C6 alkyl, and C1-C6 hydroxyalkyl. Salts of compounds of formula (I) can be prepared by treating compounds of formula (I) with a metal hydroxide (such as sodium hydroxide) or an amine (such as ammonia, trimethylamine, diethanolamine, 2-methylthiopropylamine, bisallylamine, 2-butoxyethylamine, morpholine, cyclododecylamine, or benzylamine). Amine salts are often the preferred form of compounds of formula (I) because they are water soluble and aid in the preparation of desirable aqueous herbicidal compositions.
[0019] Acceptable salts, when the compounds of the present invention contain a basic moiety, can be formed from organic and inorganic acids, such as acetic acid, propionic acid, lactic acid, citric acid, tartaric acid, succinic acid, fumaric acid, maleic acid, malonic acid, mandelic acid, malic acid, phthalic acid, hydrochloric acid, hydrobromic acid, phosphoric acid, nitric acid, sulfuric acid, methanesulfonic acid, naphthalenesulfonic acid, benzenesulfonic acid, toluenesulfonic acid, camphorsulfonic acid, and similarly known acceptable acids.
[0020] The term "herbicide" as used herein means a compound that controls or modifies the growth of plants. The term "herbicidally effective amount" means the amount of such a compound or combination of such compounds that can obtain a controlling or modifying effect on the growth of a plant. Controlling or modifying the effect includes any deviation from natural development, such as death, stunting, leaf scorch, chlorosis, dwarfing, etc. .
[0021] The present invention is based on the following generalized reaction scheme, in which rings A, R B2 , R B3 , n, R 1 , and R 2 is as defined herein.
[0022] Reaction Scheme 1 [ka] The desired halogenated pyrazole (A) is reacted with ethyl acrylate under palladium catalysis to give the substituted vinylpyrazole of formula (B). The substituted vinylpyrazole (B) undergoes cycloaddition with dithiolane-isocyanatoiminium methylide of formula (C) to give a mixture of pyrrolidine cycloadducts, i.e., compounds of formula (D) and formula (E), which can be separated by chromatography. The desired pyrrolidine cycloadduct (exemplified by compounds of formula (E) in the reaction scheme above) is reacted with a hydroxide base in a water / ether mixed solvent system to give the 3-carboxyl-substituted thiolactam of formula (X). Compounds of formula (C) can be prepared as described in Tetrahedron Lett. 1995, 36:9409. Halogenated pyrazoles of formula (A) are known or can be prepared according to methods well known in the art.
[0023] Depending on the final end product desired, the 3-carboxyl substituted thiolactam can be coupled with an aniline of formula (G) using standard amide coupling conditions such as propanephosphonic anhydride in a suitable solvent such as dichloromethane with a suitable base to provide the desired thiolactam-carboxamide of formula (H) as shown in Reaction Scheme 2 below. 2 It will be appreciated that the choice of will depend on the ultimate end product desired and therefore may be any suitable substituent capable of being amide linked.
[0024] Reaction Scheme 2 [ka] The resulting thiolactam-carboxamide of formula (H) can then undergo oxidative hydrolysis using hydrogen peroxide solution and a suitable acid to form the lactam compound of formula (I) (Reaction Scheme 3).
[0025] Reaction Scheme 3 [ka] Alternatively, the 3-carboxyl substituted thiolactam of formula (X) can then be subjected to oxidative hydrolysis using hydrogen peroxide solution and a suitable acid as shown in Reaction Scheme 4 to form the lactam compound of formula (J), which can then be coupled with an aniline of formula (G) using standard amide coupling conditions as described above to give the desired lactam compound of formula (H) (see Reaction Scheme 5 below).
[0026] Reaction Scheme 4 [ka] Reaction Scheme 5 [ka] Single enantiomers can be prepared by chiral separation, if desired. Those skilled in the art will appreciate that compounds of formula (D), (E), (X), (H), (I), and (J) can be prepared, for example, as follows: (i) For compounds of formula (D) [ka] (ii) For compounds of formula (E) [ka] (iii) For compounds of formula (X) [ka] (iv) For compounds of formula (H) [ka] (v) for compounds of formula (I) [ka] (vi) For compounds of formula (J) [ka] It will be understood that the compound may exist in different enantiomeric forms, such as:
[0027] In each case, in one set of embodiments, the enantiomers of (D1), (E1), (X1), (H1), (I1), and (J1) are preferred.
[0028] In the compounds of formula (A), (B), (D), (E), (X), (H), and (I) described herein, ring A is a pyrazole moiety bearing at least two substituents, said substituents (R B2 ) on the ring nitrogen and the second substituent (R B3 ) on a ring carbon atom. In such a configuration, A is obviously the carbon attached to the rest of the molecule.
[0029] A is disubstituted and R B3 is on a ring carbon atom adjacent to a substituted ring nitrogen atom, B3 The substituent is R B3SN For the avoidance of doubt, R B3SN R is used purely to indicate the location of a position within the pyrazole moiety B3 Since it is a definition of a sub-concept of R B3SN is also selected from the group consisting of halogen, C1-C3 fluoroalkyl, C1-C3 haloalkoxy, C1-C3 alkoxy, and C1-C3 alkyl. Thus, when A is disubstituted, the group A 1 , A 2 , A 3 , A 4 , or A 5 In the formula, R B2 , R B3 , and R B3SNis as defined above, with the jagged line indicating the point of attachment to the remainder of the relevant molecule. In compounds of formula (A), this is to the relevant halogen atom. In compounds of formula (B), this is to the ethyl-propenoate moiety. In compounds of formula (D) and (E), this is to the 1,4-dithia-6-azaspiro[4.4]nonane-8-carboxylate moiety. In compounds of formula (X), (H), and (I), this is via the 4-position carbon atom of the (thio)lactam ring. [ka]
[0030] Base A 1 and A 2 is particularly preferred, and A 2 is the most preferred disubstituted pyrazole.
[0031] When ring A is trisubstituted, it is preferably a ring having a third substituent (R B3 ) is also present on a ring carbon atom 6 Or A 7 can be represented by: [ka] (In the formula, R B2 , R B3 , R B3SN , and jagged lines are as defined above).
[0032] Preferably, R B2 is selected from the group consisting of methyl, ethyl, n-propyl, fluoromethyl, trifluoromethyl, fluoroethyl, difluoroethyl, and trifluoroethyl. More preferably, R B2 is selected from the group consisting of methyl, ethyl, n-propyl, trifluoromethyl, and difluoroethyl. More preferably, R B2 is selected from the group consisting of methyl, ethyl, and difluoroethyl.
[0033] Preferably, R B3and / or R B3SN are each independently selected from chloro, fluoro, bromo, methyl, ethyl, difluoromethyl, trifluoromethyl, C1-C3 haloalkoxy, C1-C3 alkoxy, or C1-C3 alkyl. B3 and R B3SN It will be understood that may be the same or different.
[0034] In the compounds of formula (X) as defined herein, R Q1 and R Q4 are hydrogen, and R Q2 and R Q3 together with the carbon atoms to which they are attached form an optionally substituted 5-membered thiolactam ring, Ring Q. In preferred embodiments, Q has the structure Q1 or Q2, where "a" indicates the position of attachment to Ring A and "c" indicates the position of attachment to the carboxylate moiety. [ka]
[0035] In a preferred embodiment, the Hal substituent in the compound of formula (A) is iodo or bromo.
[0036] The compounds of formula (X) can be used as intermediates in the manufacture of pharmaceuticals and agrochemicals containing a pyrazolo-pyrrolidone motif. For example, US 2007 / 0123508 describes 2-oxo-1-pyrrolidone derivatives for use as PAR2 inhibitors, and the ... the compounds of US 2007 / 0123508. 1 can be used to synthesize compounds in which R is a substituted pyrazole. US 2004 / 0242671 describes 2-oxo-1-pyrrolidine derivatives for use as therapeutic agents for treating dyskinesia, and the compound of formula (X) can be used to synthesize compounds in which R is a substituted pyrazole of formula (II) of US 2004 / 0242671. 3is a di- or tri-substituted pyrazole and R 4 can be used for compounds where
[0037] U.S. Pat. No. 4,874,422 describes 1-phenyl-3-carboxyamidopyrrolidone as a herbicide, and the compound of formula (X) can be used to prepare the compound of formula (I) described therein, but R 3 is a disubstituted pyrazole. Also described herein is the preparation of novel herbicidal compounds using compounds of formula (X).
[0038] Thus, in further aspects there is provided the use of a compound of formula (X) in the preparation of an agrochemical, in particular in the preparation of a herbicide, and the use of a compound of formula (X) in the preparation of a medicament, in particular a medicament for the prevention and / or treatment of diseases and disorders associated with PAR2 and / or for the treatment of dyskenisia.
[0039] Depending on the desired final product, R 1 is C1-C6 alkyl, C2-C6 alkenyl, C3-C6 cycloalkyl, C3-C6 cycloalkenyl, optionally substituted phenyl, optionally substituted C5-C6 heteroaryl, -CR 12 R 13 , or -C(O)R 12 R 12 is hydrogen, OH, C1-C3 alkoxy, or C1-C4 alkyl. 13 is -C(O)NH2.
[0040] When substituted, the phenyl or C5-C6 heteroaryl preferably has 1, 2, or 3 R 11 It is substituted by a substituent.
[0041] Each R 11are independently halogen, OH, C1-C6 alkyl, C1-C6 haloalkyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C1-C3 alkoxy-C1-C3 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, nitro, cyano, or amino.
[0042] In one embodiment, R 1 is 3-CF3-phenyl-.
[0043] More preferably, R 1 is C1-C3 alkyl, or -CR 12 R 13 Preferably, R 12 is methyl or ethyl, more preferably ethyl. Most preferably, R 1 is methyl.
[0044] Appropriate R 2 Examples of the substituents are hydrogen, C1-C6 alkyl, -C r Alkoxy C s Alkyl, C1-C6 haloalkyl, -C r Alkoxy C s Haloalkyl, C2-C6 alkenyl, C2-C6 alkynyl, and -(CR 21 R 22 ) t R 20 Each R 20 are independently -C(O)OR 23 , -OC(O)R 23 , -C3-C6 cycloalkyl, or an -aryl, -aryloxy, -heteroaryl, -heteroaryloxy, or -heterocyclyl ring, the ring being selected from 1 to 3 independent R 25 r is an integer of 1, 2, 3, 4, or 5, s is an integer of 1, 2, 3, 4, or 5, and the sum of r+s is 6 or less; t is an integer of 0, 1, 2, 3, 4, 5, or 6, and each R 21 are independently hydrogen or C1-C2 alkyl; each R 22 is independently hydrogen or C1-C2 alkyl; each R 23is hydrogen or C1-C4 alkyl.
[0045] In certain embodiments, R 2 1 to 3 R 25 When the aryl or heteroaryl ring is an optionally substituted aryl or heteroaryl ring selected from the group consisting of phenyl, pyridinyl, and thienyl ring systems, it can be represented by the following general structure: [ka] in which ring B is a phenyl, pyridinyl, or thienyl ring, p is an integer or 0, 1, 2, or 3, and the jagged line represents the point of attachment of the ring to the remainder of the molecule, in this case via the amide nitrogen.
[0046] In certain embodiments, R 2 is R 2 -1, R 2 -2, R 2 -3, R 2 -4, R 2 -5, and R 2 -6, where p and the jagged line are as defined above, and each R 25 are independently halogen, C1-C6 alkyl, C1-C6 haloalkyl, C1-C6 alkoxy, C1-C6 haloalkoxy, cyano, nitro, C1-C6 alkylthio, C1-C6 alkylsulfinyl, or C1-C6 alkylsulfonyl. [ka]
[0047] More preferably, each R 25are independently halogen, C1-C4 alkyl, C1-C3 haloalkyl, C1-C3 alkoxy, or C1-C3 haloalkoxy; more preferably chloro, fluoro, bromo, C1-C2 haloalkyl, C1-C2 haloalkoxy, or C1-C2 alkoxy; more preferably fluoro, ethyl, trifluoromethyl, difluoroethyl, methoxy, difluoromethoxy, or trifluoromethoxy. As described herein, the value of p is 1, 2, or 3. Preferably, p is 0, 1, or 2, and each R 25 is carried by the ring carbon atom.
[0048] In one particular set of embodiments of the compounds of formula (H) and formula (I), p is 2 and at least one R 25 is fluoro. Preferably, p is 0, 1, or 2 and each R 25 is carried by the ring carbon atom.
[0049] As noted above, compounds of formulae (B), (D), (E), (X), (H) and (I) are novel, as is compound of formula (J), and all of these compounds form further aspects of the present invention. Tables 1-7 below provide specific examples of these compounds that are within the scope of the present invention.
[0050] [Table 1]
[0051] [Table 2]
[0052] [Table 3]
[0053] [Table 4]
[0054] [Table 5-1] [Table 5-2] [Table 5-3] [Table 5-4] [Table 5-5] [Table 5-6]
[0055] [Table 6-1] [Table 6-2] [Table 6-3] [Table 6-4] [Table 6-5] [Table 6-6]
[0056] [Table 7] EXAMPLES
[0057] Example 1: Preparation of herbicide compound N-(2,3-difluorophenyl)-1-methyl-4-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]-2-oxo-pyrrolidine-3-carboxamide [ka] Salt (I) can be prepared as described in Tetrahedron Lett. 1995, 36, 9409.
[0058] Step 1 Ethyl (E)-3-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]prop-2-enoate In a large microwave vial, 3-iodo-1-methyl-5-(trifluoromethyl)pyrazole (3.62 mmol, 1.00 g) was dissolved in acetonitrile (15.2 mL), ethyl acrylate (1.19 mL, 10.9 mmol), triethylamine (0.507 mL, 3.64 mmol), tri-ortho-tolylphosphine (0.362 mmol, 0.110 g), and palladium(II) acetate (0.362 mmol, 0.0813 g) were added, the space above the stirring orange solution was swept with nitrogen, and the vial was sealed and heated under microwave irradiation at 110° C. for 60 min. The reaction mixture was filtered (washed with a small amount of EtOAc) and the combined filtrate and washings were concentrated to remove most of the solvent. The remaining orange-brown liquid was diluted with water (12 mL) and extracted with EtOAc (3×15 mL). The organic extracts were combined, washed with water (10 mL), passed through a phase separation cartridge and concentrated. Column chromatography (eluting with a gradient of EtOAc / iso-hexane) afforded 0.51 g (57%) of ethyl (E)-3-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]prop-2-enoate as a yellow oil. 1 H NMR:(400MHz,CDCl3):δ=7.58(d,J=16.1Hz,1H),6.81(s,1H),6.43(d,J=16. 1Hz,1H),4.26(q,J=7.1Hz,2H),4.01(d,J=0.6Hz,3H),1.33(t,J=7.1Hz,3H).
[0059] Step 2: Ethyl-6-methyl-8-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]-1,4-dithia-6-azaspiro[4.4]nonane-9-carboxylate To a suspension of finely ground cesium fluoride (12.7 mmol, 1.93 g) in tetrahydrofuran (9.51 mL) stirred at -50°C under nitrogen was added a solution of ethyl (E)-3-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]prop-2-enoate (3.17 mmol, 0.787 g) and 1,3-dithiolan-2-ylidene-methyl-(trimethylsilylmethyl)ammonium, and trifluoromethanesulfonic acid (5.55 mmol, 2.06 g) in tetrahydrofuran (39.51 mL) was added dropwise over approximately 15 min, keeping the reaction temperature below -45°C. The resulting very pale yellow cloudy suspension was allowed to slowly warm to room temperature and stirring was continued overnight. The reaction mixture was then diluted with DCM, filtered, and rinsed thoroughly with additional DCM. The combined filtrate and washings were concentrated and the crude material was purified by column chromatography (eluting with a gradient of EtOAc / cyclohexane) to give 566 mg (45%) of ethyl-6-methyl-8-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]-1,4-dithia-6-azaspiro[4.4]nonane-9-carboxylate as a pale yellow oil. 1 H NMR:(400MHz,CDCl3):δ=6.45(s,1H),4.31-4.17(m,2H),3.90(d,J=0.6Hz,3H),3.89- 3.79(m,2H),3.35-3.06(m,5H),2.97-2.91(m,1H),2.47(s,3H),1.31(t,J=7.2Hz,3H).
[0060] Step 3: 1-Methyl-4-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]-2-thioxo-pyrrolidine-3-carboxylic acid To a solution of ethyl 6-methyl-8-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]-1,4-dithia-6-azaspiro[4.4]nonane-9-carboxylate (1.43 mmol, 0.566 g) in dioxane (34.3 mL) and water (11.4 mL) was added LiOH (14.3 mmol, 0.343 g) and the stirred mixture was heated to 60° C. for 1 h under a nitrogen atmosphere. The reaction mixture was then cooled to about 35° C. and then concentrated to remove most of the dioxane. The remaining mixture was diluted with water (10 mL) and partitioned between dilute HCl (5 mL, to pH 3) and DCM (20 mL). The biphasic mixture was filtered to remove fine solids and then the organic phase was separated. The aqueous phase was further extracted with DCM (2 x 15 mL) and all organic extracts were combined, dried over MgSO4, filtered and the filtrate was concentrated to give 399 mg (90%) of 1-methyl-4-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl-2-thioxo-pyrrolidine-3-carboxylic acid as a pale yellow solid. 1 H NMR:(400MHz,CDCl3):δ=6.66(s,1H),4.19-4.03(m,4H),3.93(d,J=0.5Hz,3H),3.34(s,3H).
[0061] Step 4 N-(2,3-difluorophenyl)-1-methyl-4-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]-2-thioxo-pyrrolidine-3-carboxamide To a solution of 1-methyl-4-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]-2-thioxo-pyrrolidine-3-carboxylic acid (0.340 g, 1.11 mmol) in DCM (8.0 mL) was added 2,3-difluoroaniline (0.112 mL, 1.11 mmol) to give a pale yellow solution. Propanephosphonic anhydride (50% by weight) in ethyl acetate (1.88 mmol, 1.12 mL) was added, followed by N,N-diisopropylamine (3.32 mmol, 0.578 mL) and the reaction mixture was stirred at room temperature for 1 h. The reaction mixture was then quenched by the addition of water (2 mL) with stirring, transferred to a phase separation cartridge and the organics were collected and concentrated. Column chromatography (eluting with a gradient of EtOAc / isohexane) afforded 264 mg (57%) of N-(2,3-difluorophenyl)-1-methyl-4-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]-2-thioxo-pyrrolidine-3-carboxamide as a colourless crystalline solid. 1 H NMR:(400MHz,CDCl3):δ=10.25(br s,1H),8.01(tdd,J=1.6,6.6,8.3Hz,1H),7.04(ddt,J=2.1,5.9,8.3Hz,1H),6.94-6.86(m,1H),6.58(s,1H) ,4.40(td,J=6.3,8.6Hz,1H),4.20(d,J=6.4Hz,1H),4.13(dd,1H),4.00(dd,1H),3.93(d,3H),3.33(s,3H).
[0062] Step 5 N-(2,3-difluorophenyl)-1-methyl-4-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]-2-oxo-pyrrolidine-3-carboxamide To a stirred solution of N-(2,3-difluorophenyl)-1-methyl-4-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]-2-thioxo-pyrrolidine-3-carboxamide (0.621 mmol, 0.260 g) in acetonitrile (6.21 mL) cooled to about 0 to -5 °C in an ice-salt bath, 50% hydrogen peroxide (0.746 mL) was added dropwise to give a white suspension. After 5 min, 45% aqueous hydrobromic acid (0.0750 mL, 0.621 mmol) was added dropwise and after stirring for 10 min, the mixture was allowed to warm to room temperature. After 3 h, the reaction mixture was recooled to 5 °C and quenched with sodium thiosulfate solution (ca. 10 mL). The mixture was diluted with EtOAc (15 mL) and water (10 mL) and the organic phase was separated. The aqueous phase was further extracted with EtOAc (2 x 10 mL), then the combined organic extracts were passed through a phase separation cartridge and then concentrated to give a colourless gum. Column chromatography (eluting with a gradient of EtOAc / iso-hexane) afforded 210 mg (84%) of N-(2,3-difluorophenyl)-1-methyl-4-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]-2-oxo-pyrrolidine-3-carboxamide as a white crystalline solid. 1 H NMR:(400MHz,CDCl3):δ=10.15(br s,1H),8.04(dd,J=6.6,8.3Hz,1H),7.06-6.99(m,1H),6.89(br dd,J=1.1,8.6Hz,1H),6.69(s,1H),4.09(q,1H),3.94(s,3H),3.78(d,J=9.5Hz,1H),3.76-3.65(m,2H),2.98(d,3H).
[0063] Using sc-CO2 (solvent A) and isopropanol (solvent B) as solvents, the solvents were analyzed under isocratic conditions: 85% solvent A: 15% solvent B at 15 mL / min using Chiralpak Using a 10×250 mm, 5 μm column, racemic N-(2,3-difluorophenyl)-1-methyl-4-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]-2-oxo-pyrrolidine-3-carboxamide can be separated to give the enantiomers (3S,4R)-N-(2,3-difluorophenyl)-1-methyl-4-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]-2-oxo-pyrrolidine-3-carboxamide and (3R,4S)-N-(2,3-difluorophenyl)-1-methyl-4-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]-2-oxo-pyrrolidine-3-carboxamide.
[0064] Additional examples of herbicidal compounds of formula (I) were prepared using the methods and compounds of the invention described herein in a manner directly analogous to N-(2,3-difluorophenyl)-1-methyl-4-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]-2-oxo-pyrrolidine-3-carboxamide described in Example 1 above. The structures and characteristic NMR data for these compounds are shown in Table 8 below.
[0065] [Table 8-1] [Table 8-2]
Claims
1. Compound of formula (X): (X) (Wherein, ring A is A 1 or A 2 ; R B2 is selected from the group consisting of methyl, ethyl, n-propyl, trifluoromethyl, and difluoroethyl; R B3SN is chloro, fluoro, bromo, methyl, ethyl, difluoromethyl, trifluoromethyl, C 1 -C 3 haloalkoxy, or C 1 -C 3 alkoxy; The jagged line indicates the point of attachment to the remainder of the compound of formula (X); R Q1 and R Q4 are each hydrogen; R Q2 and R Q3 together with the carbon atom to which they are attached, form a ring Q, where ring Q is Q1 or Q2. wherein R 1 is methyl; and "a" indicates the position of attachment to Ring A and "c" indicates the position of attachment to the carboxylate moiety).
2. (i) reacting a compound of formula (A) with ethyl acrylate under palladium catalysis to obtain a compound of formula (B): (Wherein, (a) the compound of formula (A) is selected from the group consisting of A 1 * and A 2 * (In the formula, R B2 are independently methyl, ethyl, n-propyl, trifluoromethyl or difluoroethyl, R B3 SN is chloro, fluoro, bromo, methyl, ethyl, difluoromethyl, trifluoromethyl, C 1 -C 3 haloalkoxy, or C 1 -C 3 alkoxy; Hal is halogen; and (b) ring A of formula (B) is as defined in claim 1); (ii) reacting said compound of formula (B) from step (i) with a compound of formula (C) in a cycloaddition reaction to obtain a mixture of compounds of formula (D) and (E): (In the formula, R 1 is methyl); (iii) reacting the compound of formula (E) with a hydroxide base in a water / ether mixed solvent system to obtain the compound of formula (X): (Wherein, rings A and R 1 is as defined in steps (i) and (ii) above); A method for preparing a compound of formula (X) according to claim 1, comprising:
3. (iv) reacting said compound of formula (X) from step (iii) with an amine of formula (G) using propanephosphonic anhydride in a suitable solvent containing a suitable base to obtain a thiolactam-carboxamide of formula (H); 3. The method of claim 2 further comprising: R 2 is selected from the group consisting of R 2 -1, R 2 -2, R 2 -3, R 2 -4, R 2 -5, and R 2 -6; In the formula, p is 0, 1, 2, 3 or an integer; the jagged line indicates the point of attachment to the amide nitrogen of the ring; and Each R 25 are independently halogen, C 1 ~C4 alkyl, C 1 ~C3 haloalkyl, C 1 ~Calkoxy or C 1 -C3 haloalkoxy).
4. 13. Use of a compound of formula (X) as defined in claim 1 in the manufacture of a pharmaceutical or agrochemical.
5. The use according to claim 4, wherein the pesticide is a herbicide.
6. 2. Use of a compound of formula (B) in the preparation of a compound of formula (X) according to claim 1. (Wherein, ring A is A 1 or A 2 ; R B2 is C 1 ~C 3 Alkyl or C 1 ~C 3 is fluoroalkyl; R B3SN is chloro, fluoro, bromo, methyl, ethyl, difluoromethyl, trifluoromethyl, C 1 -C 3 haloalkoxy, or C 1 -C 3 alkoxy; the jagged line indicates the point of attachment to the remainder of the compound of formula (B).
7. Compound of formula (E): (wherein ring A is A 1 or A 2 ; R B2 is C 1 ~C 3 Alkyl or C 1 ~C 3 is fluoroalkyl; R B3SN is chloro, fluoro, bromo, methyl, ethyl, difluoromethyl, trifluoromethyl, C 1 -C 3 haloalkoxy, or C 1 -C 3 alkoxy; The jagged line indicates the point of attachment to the remainder of the compound of formula (E); R 1 is methyl).
8. Compound of formula (H): (wherein ring A is A 1 or A 2 ; R B2 is C 1 ~C 3 Alkyl or C 1 ~C 3 is fluoroalkyl; R B3SN is chloro, fluoro, bromo, methyl, ethyl, difluoromethyl, trifluoromethyl, C 1 -C 3 haloalkoxy, or C 1 -C 3 alkoxy; The jagged line indicates the point of attachment to the remainder of the compound of formula (H): R 1 is methyl; R 2 is selected from the group consisting of R 2 -1, R 2 -2, R 2 -3, R 2 -4, R 2 -5, and R 2 -6; In the formula, p is 0, 1, 2, 3 or an integer; The jagged line indicates the point of attachment of R2 to the amide nitrogen; and Each R 25 is independently halogen, C 1 -C 4 alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 alkoxy or C 1 -C 3 haloalkoxy.
9. Compound of formula (J): (Wherein, ring A is A 1 or A 2 ; R B2 is C 1 ~C 3 Alkyl or C 1 ~C 3 is fluoroalkyl; R B3SN is chloro, fluoro, bromo, methyl, ethyl, difluoromethyl, trifluoromethyl, C 1 -C 3 haloalkoxy, or C 1 -C 3 alkoxy; the jagged line indicates the point of attachment to the remainder of the compound of formula (J); R 1 is methyl).
10. Compound of formula (D): (wherein ring A is A 1 or A 2 ; R B2 is C 1 ~C 3 Alkyl or C 1 ~C 3 is fluoroalkyl; R B3 is chloro, fluoro, bromo, methyl, ethyl, difluoromethyl, trifluoromethyl, C 1 -C 3 haloalkoxy, or C 1 -C 3 alkoxy; R B3SN is an R B3 substituent located on the carbon atom immediately adjacent to the nitrogen atom substituted with R B2 , with the jagged line indicating the point of attachment to the remainder of the compound of formula (D); 1 is methyl).
Citation Information
Patent Citations
Prophylactic and therapeutic agent for neuropathy
JP2004168768A
Method for producing arylvinyl halide or sulfonate and arylalkyne and compounds produced thereby
JP2004210788A
pyrrolidinone herbicide
JP2017506210A
Substituted cyclic amides and their use as herbicides
JP2018522832A
N-cyclopropyl-2-oxopyrrolidine-3-carboxamide derivatives and related compounds as herbicidal plant protection agents
WO2018177836A1
